Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.
Details
State: Public
Version: Final published version
License: Not specified
Serval ID
serval:BIB_12A8F7D8B626
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.
Journal
Haematologica
ISSN
1592-8721 (Electronic)
ISSN-L
0390-6078
Publication state
Published
Issued date
01/2018
Peer-reviewed
Oui
Volume
103
Number
1
Pages
e39-e41
Language
english
Notes
Publication types: Case Reports ; Journal Article
Publication Status: ppublish
Publication Status: ppublish
Keywords
Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biomarkers, Biopsy, Combined Modality Therapy, Histiocytic Sarcoma/diagnosis, Histiocytic Sarcoma/drug therapy, Histiocytic Sarcoma/metabolism, Humans, Imatinib Mesylate/administration & dosage, Immunohistochemistry, Immunophenotyping, Male, Molecular Targeted Therapy, Positron Emission Tomography Computed Tomography, Pyridones/administration & dosage, Pyrimidinones/administration & dosage, Retreatment, Symptom Assessment, Treatment Outcome
Pubmed
Web of science
Open Access
Yes
Create date
07/11/2017 8:18
Last modification date
21/11/2022 8:11
Usage data
